Connect Sign In
Chromosome FISH, CLL Panel
Ordering Recommendation
Alternate test to detect prognostically important genomic abnormalities in CLL.
Methodology
Fluorescence in situ Hybridization (FISH)
Performed
Sun-Sat
Reported
3-10 days
New York DOH Approval Status
Specimen Required
Green (sodium heparin). Also acceptable: Non-diluted bone marrow aspirate collected in a heparinized syringe.
Transport 5 mL whole blood (Min: 2 mL). OR Transfer 3 mL bone marrow to a green (sodium heparin) (Min: 1 mL)
Room temperature.
Frozen specimens. Paraffin-embedded specimens. Clotted specimens.
Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable.
Reference Interval
By report
Interpretive Data
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Analyte Specific Reagent (ASR)
Note
Fluorescence in situ Hybridization panel is performed for CLL prognosis-specific genomic abnormalities as follows: ATM deletion, D13S319 deletion, Trisomy 12, TP53 deletion.
A processing fee will be charged if this procedure is canceled at the client's request, after the test has been set up, or if the specimen integrity is inadequate to allow culture growth
If cell pellets or dropped cytogenetic slides are submitted, processing fee will not apply.
This test must be ordered using Oncology test request form #43099 or through your ARUP interface.
Hotline History
CPT Codes
88271 x4; 88275 x4
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0092616 | Chromosome FISH, CLL Panel | 57802-1 |
| 2002197 | EER Chromosome FISH, CLL Panel | 11526-1 |
Aliases
- 'Chronic Lymphocytic Leukemia FISH Panel
Feedback
